Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phallus indusiatus aqueous extract is a natural product derived from the bamboo mushroom (*Phallus indusiatus*), an edible fungus traditionally used in Asian medicine. The extract is rich in bioactive polysaccharides and has been investigated in preclinical research for its antioxidant, anti-inflammatory, and anticancer properties. In oncology research, it has been shown to induce apoptosis in breast cancer cells (such as MCF-7) by inhibiting the NF-kappaB and Akt signaling pathways, particularly within inflammatory tumor microenvironments. Additionally, it exhibits anti-melanogenic effects by inhibiting tyrosinase and promotes wound healing by stimulating collagen production through the modulation of matrix metalloproteinase-2 (MMP-2). It is currently utilized as a research tool and a potential lead for cosmeceutical and therapeutic development rather than as a commercial pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phallus indusiatus aqueous extract.